Alnylam Pharmaceuticals, Inc. (ALNY)
236.06
-0.16
(-0.07%)
USD |
NASDAQ |
Aug 24, 16:00
237.08
+1.02
(+0.43%)
After-Hours: 19:20
Alnylam Pharmaceuticals Price to Book Value : 23.31 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 23.33 |
| August 20, 2026 | 22.65 |
| August 19, 2026 | 23.96 |
| August 18, 2026 | 22.58 |
| August 17, 2026 | 22.18 |
| August 14, 2026 | 22.58 |
| August 13, 2026 | 22.43 |
| August 12, 2026 | 22.12 |
| August 11, 2026 | 21.85 |
| August 10, 2026 | 21.43 |
| August 07, 2026 | 21.65 |
| August 06, 2026 | 21.34 |
| August 05, 2026 | 22.59 |
| August 04, 2026 | 21.63 |
| August 03, 2026 | 21.76 |
| July 31, 2026 | 20.30 |
| July 30, 2026 | 20.29 |
| July 29, 2026 | 28.31 |
| July 28, 2026 | 28.48 |
| July 27, 2026 | 27.50 |
| July 24, 2026 | 26.84 |
| July 23, 2026 | 26.54 |
| July 22, 2026 | 26.37 |
| July 21, 2026 | 26.80 |
| July 20, 2026 | 26.93 |
| Date | Value |
|---|---|
| July 17, 2026 | 26.42 |
| July 16, 2026 | 27.96 |
| July 15, 2026 | 27.57 |
| July 14, 2026 | 27.78 |
| July 13, 2026 | 28.45 |
| July 10, 2026 | 29.51 |
| July 09, 2026 | 30.89 |
| July 08, 2026 | 31.95 |
| July 07, 2026 | 31.76 |
| July 06, 2026 | 30.92 |
| July 02, 2026 | 30.89 |
| July 01, 2026 | 29.79 |
| June 30, 2026 | 29.73 |
| June 29, 2026 | 36.42 |
| June 26, 2026 | 36.16 |
| June 25, 2026 | 36.38 |
| June 24, 2026 | 36.49 |
| June 23, 2026 | 35.76 |
| June 22, 2026 | 35.54 |
| June 18, 2026 | 34.51 |
| June 17, 2026 | 35.08 |
| June 16, 2026 | 34.98 |
| June 15, 2026 | 35.71 |
| June 12, 2026 | 35.10 |
| June 11, 2026 | 35.91 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 23.36 |
| Regeneron Pharmaceuticals, Inc. | 2.702 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| BridgeBio Pharma, Inc. | -- |
| Pfizer Inc. | 1.872 |
Price to Book Value Related Metrics
| PE Ratio | 39.86 |
| PS Ratio | 6.758 |
| Price to Free Cash Flow | 40.89 |
| Price | 236.06 |
| Earnings Yield | 2.51% |
| Market Cap | 31.57B |
| Operating PE Ratio | 32.47 |
| Normalized PE Ratio | 41.01 |